直肠乙状结肠深部浸润型子宫内膜异位结节进展研究
单中心病例对照研究纳入43例直肠乙状结肠深部子宫内膜异位症患者,两次MRI间隔至少12个月。60.5%病灶稳定,27.9%进展,11.6%退缩;进展组无月经中位时间占比显著低于稳定组和退缩组,持续无月经者未见进展。
要点
- 27.9%的直肠乙状结肠深部内异结节在两次MRI间进展,60.5%稳定,11.6%退缩。
- 进展组无月经时间占比中位数15.1%,显著低于稳定组19.2%和退缩组94.1%(P=0.006)。
- 持续无月经(药物、哺乳或妊娠所致)患者中未见结节进展。
核心结论
- 直肠乙状结肠深部子宫内膜异位结节存在进展风险,尤其在未达到持续无月经的月经期女性中。
- 药物、哺乳或妊娠诱导的无月经女性中,结节进展风险很低。
研究设计与样本
- 2016年9月至2018年3月在鲁昂大学医院开展的单中心病例对照研究,纳入43例直肠乙状结肠深部子宫内膜异位症患者,两次MRI间隔至少12个月且期间未接受手术治疗。
- 由经验丰富的资深放射科医生重新解读MRI,测量深部浸润结直肠病灶长度和厚度,并在30例随机选取病例中检验观察者内和观察者间信度。
主要发现
- 两次MRI平均间隔(标准差)为38.3(22.1)个月。
- 60.5%患者病灶稳定,27.9%符合进展标准(长度或厚度增加≥20%),11.6%符合退缩标准(长度或厚度减少≥20%)。
- 三组间两次MRI间隔时间无显著差异(P=0.76)。
- 进展组无月经中位持续时间7.5个月,显著低于稳定组8.5个月和退缩组21个月(P<0.001)。
- 进展组无月经时间占总间隔百分比中位数15.1%,显著低于稳定组19.2%和退缩组94.1%(P=0.006)。
关键数值与推荐
- 进展定义为两次MRI间结节长度或厚度增加≥20%,退缩定义为减少≥20%,变化<20%为稳定。
- 进展组无月经中位持续时间7.5个月 vs 稳定组8.5个月 vs 退缩组21个月(P<0.001)。
- 进展组无月经时间占比中位数15.1% vs 稳定组19.2% vs 退缩组94.1%(P=0.006)。
- 无持续无月经者中进展比例34%,从未无月经者中39%,持续无月经者中0%。
临床怎么用
- 作者认为,未行手术治疗的直肠乙状结肠深部子宫内膜异位结节患者应接受监测以发现结节生长,尤其未达到持续无月经时。
- 作者认为,该建议对计划首次辅助生殖技术助孕的年轻直肠乙状结肠结节患者重要。
- 作者指出,药物、哺乳或妊娠诱导无月经的女性中,直肠乙状结肠深部内异结节进展风险很低。
局限性
- 原文指出,由于缺乏 universally 公认的MRI深部内异结节进展或退缩判定标准,本研究采用的阈值可能存有争议。
- 原文指出,由于回顾性设计,两次MRI间隔时间、所用MRI技术、无月经原因及无月经持续时间可能存在异质性。
- 原文指出,两次MRI平均间隔时间较短且患者间存在差异。
- 原文指出, findings 仅针对直肠乙状结肠深部内异症,不能未经谨慎外推至其他部位结节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the risk of progression of deep endometriotic nodules infiltrating the rectosigmoid? SUMMARY ANSWER: There is a risk of progression of deep endometriotic nodules infiltrating the rectosigmoid, particularly in menstruating women. WHAT IS KNOWN ALREADY: Currently, there is a lack of acceptance in the literature on the probability that deeply infiltrating rectosigmoid endometriotic nodules progress in size. STUDY DESIGN, SIZE, DURATION: We conducted a monocentric case-control study between September 2016 and March 2018 at Rouen University Hospital. We enrolled 43 patients who were referred to our tertiary referral centre with deep endometriosis infiltrating the rectosigmoid, who had undergone two MRI examinations at least 12 months apart and had not undergone surgical treatment of rectosigmoid endometriosis during this interval. PARTICIPANTS/MATERIALS, SETTING, METHODS: MRI images were reinterpreted by a senior radiologist with experience and expertise in endometriosis, who measured the length and thickness of deep infiltrating colorectal lesions. Intra- and inter-observer reliability were tested on 30 randomly selected cases. We defined 'progression' of a nodule as an increase of ≥20% in length or in thickness and 'regression' of a lesion as a decrease of ≥20% in length or in thickness between two MRIs. Any nodule for which the variation in length and thickness was <20% was considered as 'stable'. Patients were divided into three groups based on evidence of progression, regression or stability of deep endometriotic nodules between their two MRI examinations. The total length of any period of amenorrhoea between the two MRI examinations, due to pregnancy, breastfeeding or hormonal treatment, was recorded. The total proportion of the time between MRIs where amenorrhoea occurred was compared between groups. MAIN RESULTS AND THE ROLE OF CHANCE: Eighty-six patients underwent at least two MRIs for deep endometriosis infiltrating the sigmoid or rectum between September 2016 and March 2018. Of these, we excluded 10 patients with an interval of <12 months between MRIs, 10 patients who underwent surgery between MRIs, 17 patients for whom at least 1 MRI was considered to be of poor quality and 6 patients for whom no deep colorectal lesion was found on repeat review of either MRI. This resulted in a total of 43 patients eligible for enrolment in the final analysis. Mean time (SD) between MRIs was 38.3 (22.1) months. About 60.5% of patients demonstrated stability of their colorectal lesions between the two MRIs, 27.9% of patients met the criteria for 'progression' of lesions and 11.6% met the criteria for 'regression' of lesions. There was no significant difference in time interval between MRIs for the three groups (P = 0.76). Median duration of amenorrhoea was significantly lower in women with progression of lesions (7.5 months) when compared to those with stability of lesions (8.5 months) or regression of lesions (21 months) (P < 0.001). Median duration of amenorrhoea (expressed as percentage of total time between two MRIs) was also found to be significantly lower in the group demonstrating progression (15.1%) when compared to the group demonstrating stability (19.2%) and the group demonstrating regression (94.1%; P = 0.006). Progression of rectosigmoid nodules was observed in 34% of patients without continuous amenorrhoea, in 39% who had never had amenorrhoea and in no patients with continuous amenorrhoea. LIMITATIONS, REASONS FOR CAUTION: Due to a lack of universally accepted criteria for defining the progression or regression of deep endometriotic nodules on MRI, the values used in our study may be disputed. Due to the retrospective design of the study, there may be heterogeneity of interval between MRIs, MRI techniques used, reason for amenorrhoea and duration of amenorrhoea. The mean inter-MRI interval was of short duration and varied between patients. Our findings are reported for only deep endometriosis infiltrating the rectosigmoid and cannot be extrapolated, without caution, to nodules of other locations. WIDER IMPLICATIONS OF THE FINDINGS: Patients with deeply infiltrating rectosigmoid endometriotic nodules, for which surgical management has not been performed, should undergo surveillance to allow detection of growth of nodules, particularly when continuous amenorrhoea has not been achieved. This recommendation is of importance to young patients with rectosigmoid nodules who wish to conceive, in whom first line ART is planned. There is a very low risk of progression of deep endometriotic nodules infiltrating the rectosigmoid in women with amenorrhoea induced by medical therapy, lactation or pregnancy. STUDY FUNDING/COMPETING INTEREST(S): No funding was received for this study. The authors declare no competing interests related to this study.
引用
- Netter A, d'Avout-Fourdinier P, Agostini A, et al. Progression of deep infiltrating rectosigmoid endometriotic nodules. Hum Reprod. 2019. PMID: 31687764. doi:10.1093/humrep/dez188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。